MedTrace Logo

Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia

NCT00807625 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2012-07-13

No results posted yet for this study

Summary

In this study, 66 HIV-infected women who desire contraception will be randomly assigned to use either an IUD or Depo Provera, and will be followed for six months. The study is intended to help investigators understand potential mechanisms by which hormonal contraception may hasten HIV disease progression.

Conditions

  • HIV
  • Contraception
  • HIV Infections

Interventions

DRUG

Depo Provera

Depo Provera administered by injection at randomization visit and the 12-week study visit.

DEVICE

Copper T Intrauterine contraception device

IUCD inserted upon randomization to this study arm

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Elizabeth M Stringer, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807625 on ClinicalTrials.gov